Elevated levels of salivary interleukin-34 in patients suffering from Alzheimer’s disease
Identifying reliable biomarkers for AD is crucial for early detection and intervention. This study suggests that salivary IL-34 could serve as a potential biomarker for AD.
Authors
- Ronaldo Lira‐Junior (ORCID: https://orcid.org/0000-0003-0297-5138)
- Marianne Schultzberg (ORCID: https://orcid.org/0000-0002-8314-0927)
- Maria Eriksdotter (ORCID: https://orcid.org/0000-0003-2498-4000)
- Reuben Clark (ORCID: https://orcid.org/0000-0003-0527-4572)
- Elisabeth A. Boström (ORCID: https://orcid.org/0000-0003-1788-7501)
- Leif Jansson (ORCID: https://orcid.org/0000-0001-5923-5777)
- Kåre Buhlin (ORCID: https://orcid.org/0000-0003-3799-8567)
- Pirkko J. Pussinen (ORCID: https://orcid.org/0000-0003-3563-1876)
Institutions
- Karolinska University Hospital (SE)
- University of Helsinki (FI)
- University of Eastern Finland (FI)
- Karolinska Institutet (SE)
- Stockholm Health Care Services (SE)
Publication Details
- Journal
- Clinical Oral Investigations
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1007/s00784-025-06376-4
- Citations
- 3
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 2.53
Funders
- VINNOVA
- Karolinska Institutet
- Vetenskapsrådet
- Svenska Tandläkare-Sällskapet